Drug Shortage Report for POLYMYXIN B FOR INJECTION USP
| Report ID | 8303 |
| Drug Identification Number | 02375893 |
| Brand name | POLYMYXIN B FOR INJECTION USP |
| Common or Proper name | POLYMYXIN B FOR INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | POLYMYXIN B |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC |
| Packaging size | 1 VIAL |
| ATC code | J01XB |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2017-01-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | BUSINESS REASONS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-04-27 | French | Compare |
| v1 | 2017-04-27 | English | Compare |
Showing 1 to 2 of 2